newsfilter
← Latest News
Business Wire·

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

Merger to result in NYSE American-listed company focused on developing therapeutics based on Serina's proprietary POZ Platform™ delivery technology Lead program of the combined company will be SER-252